163 related articles for article (PubMed ID: 34497663)
1. Establishment of an Immune-Related Gene Signature for Risk Stratification for Patients with Glioma.
He J; Zeng C; Long Y
Comput Math Methods Med; 2021; 2021():2191709. PubMed ID: 34497663
[TBL] [Abstract][Full Text] [Related]
2. Identification and validation of a risk signature based on extracellular matrix-related genes in gliomas.
Liu J; Li G
Medicine (Baltimore); 2021 Apr; 100(16):e25603. PubMed ID: 33879726
[TBL] [Abstract][Full Text] [Related]
3. A novel pyroptosis-related gene signature predicts the prognosis of glioma through immune infiltration.
Zhang M; Cheng Y; Xue Z; Sun Q; Zhang J
BMC Cancer; 2021 Dec; 21(1):1311. PubMed ID: 34876094
[TBL] [Abstract][Full Text] [Related]
4. Multicellular gene network analysis identifies a macrophage-related gene signature predictive of therapeutic response and prognosis of gliomas.
Sun X; Liu X; Xia M; Shao Y; Zhang XD
J Transl Med; 2019 May; 17(1):159. PubMed ID: 31097021
[TBL] [Abstract][Full Text] [Related]
5. Identification of three tumor antigens and immune subtypes for mRNA vaccine development in diffuse glioma.
Zhou Q; Yan X; Zhu H; Xin Z; Zhao J; Shen W; Yin W; Guo Y; Xu H; Zhao M; Liu W; Jiang X; Ren C
Theranostics; 2021; 11(20):9775-9790. PubMed ID: 34815785
[No Abstract] [Full Text] [Related]
6. Identification of a robust biomarker LAPTM4A for glioma based on comprehensive computational biology and experimental verification.
Ding Y; Jiang Y; Zeng H; Zhou M; Zhou X; Yu Z; Pan J; Geng X; Zhu Y; Zheng H; Huang S; Gong Y; Huang H; Xiong C; Huang D
Aging (Albany NY); 2024 Apr; 16(8):6954-6989. PubMed ID: 38613802
[TBL] [Abstract][Full Text] [Related]
7. ITGB2 as a prognostic indicator and a predictive marker for immunotherapy in gliomas.
Xu H; Zhang A; Han X; Li Y; Zhang Z; Song L; Wang W; Lou M
Cancer Immunol Immunother; 2022 Mar; 71(3):645-660. PubMed ID: 34313821
[TBL] [Abstract][Full Text] [Related]
8. Novel prognostic biomarker TBC1D1 is associated with immunotherapy resistance in gliomas.
Song D; Yang Q; Li L; Wei Y; Zhang C; Du H; Ren G; Li H
Front Immunol; 2024; 15():1372113. PubMed ID: 38529286
[TBL] [Abstract][Full Text] [Related]
9. Novel roles of VAT1 expression in the immunosuppressive action of diffuse gliomas.
Yang P; Wang K; Zhang C; Wang Z; Liu Q; Wang J; Jiang T; Shan X
Cancer Immunol Immunother; 2021 Sep; 70(9):2589-2600. PubMed ID: 33576871
[TBL] [Abstract][Full Text] [Related]
10. Analysis of the sodium pump subunit ATP1A3 in glioma patients: Potential value in prognostic prediction and immunotherapy.
Lan YL; Zou S; Qin B; Zhu X
Int Immunopharmacol; 2024 May; 133():112045. PubMed ID: 38615384
[TBL] [Abstract][Full Text] [Related]
11. Identification of M5c regulator-medicated methylation modification patterns for prognosis and immune microenvironment in glioma.
Xiao Z; Li J; Liang C; Liu Y; Zhang Y; Zhang Y; Liu Q; Yan X
Aging (Albany NY); 2023 Nov; 15(21):12275-12295. PubMed ID: 37934565
[TBL] [Abstract][Full Text] [Related]
12. Integrated profiling identifies CACNG3 as a prognostic biomarker for patients with glioma.
Shan E; Cao YN; Zhang Y; Chen W; Ren X; Zhu S; Xi X; Mu S; Ma M; Zhi T; Li X
BMC Cancer; 2023 Sep; 23(1):846. PubMed ID: 37697240
[TBL] [Abstract][Full Text] [Related]
13. Comprehensive analysis reveals that LTBR is a immune-related biomarker for glioma.
Tang Q; Yuan Y; Li L; Xu Y; Ji W; Xiao S; Han Y; Miao W; Cai J; You P; Chen M; Ding S; Li Z; Qi Z; Hou W; Luo H
Comput Biol Med; 2024 May; 174():108457. PubMed ID: 38599071
[TBL] [Abstract][Full Text] [Related]
14. Prognosis prediction based on methionine metabolism genes signature in gliomas.
Zhou S; Zhao X; Zhang S; Tian X; Wang X; Mu Y; Li F; Zhao AZ; Zhao Z
BMC Med Genomics; 2023 Dec; 16(1):317. PubMed ID: 38057821
[TBL] [Abstract][Full Text] [Related]
15. THOC6 is a novel biomarker of glioma and a target of anti-glioma drugs: An analysis based on bioinformatics and molecular docking.
Wei C; Gao Y; Li P
Medicine (Baltimore); 2024 May; 103(19):e37999. PubMed ID: 38728502
[TBL] [Abstract][Full Text] [Related]
16. A novel NFAT1-IL6/JAK/STAT3 signaling pathway related nomogram predicts overall survival in gliomas.
Zhang C; Wang Y; Shao W; Zhou D; Yu D; Hou S; Lin N
Sci Rep; 2023 Jul; 13(1):11401. PubMed ID: 37452092
[TBL] [Abstract][Full Text] [Related]
17. Identification of a novel disulfideptosis-related gene signature for prognostic implication in lower-grade gliomas.
Zhang F; Lv M; He Y
Aging (Albany NY); 2024 Mar; 16(7):6054-6067. PubMed ID: 38546389
[TBL] [Abstract][Full Text] [Related]
18. A lipid metabolism-related risk signature for patients with gliomas constructed with TCGA and CGGA data.
Meng D; Liu T
Medicine (Baltimore); 2022 Sep; 101(36):e30501. PubMed ID: 36086728
[TBL] [Abstract][Full Text] [Related]
19. Integrated bioinformatics analysis and experimental validation identified CDCA families as prognostic biomarkers and sensitive indicators for rapamycin treatment of glioma.
Li R; Chen Y; Yang B; Li Z; Wang S; He J; Zhou Z; Li X; Li J; Sun Y; Guo X; Wang X; Wu Y; Zhang W; Guo G
PLoS One; 2024; 19(1):e0295346. PubMed ID: 38181024
[TBL] [Abstract][Full Text] [Related]
20. Establishment of glioma prognosis nomogram based on the function of meox1 in promoting the progression of cancer.
Pan P; Guo A; Peng L
Heliyon; 2024 May; 10(9):e29827. PubMed ID: 38707372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
